lyratherapeutics.com (LYRA): Net earnings per share growth forecast for next year

Corporate company logo of lyratherapeutics.com (LYRA)

The development of targeted drug delivery in the ENT sector allows for the treatment of pathologies without surgery. The annual EPS forecast for Lyra Therapeutics, Inc. (LYRA) demonstrates volatility, with the current level sitting around 0.00. The business is currently seeking partners for molecule licensing following a portfolio restructuring, relying on external contractors to conduct clinical trials and produce sterile matrices.

Lyra Therapeutics Inc (LYRA): Net earnings per share growth forecast for next year from 07/04/2022 to 03/28/2026

Lyra Therapeutics - analytical breakdowns and key metrics (LYRA)

- share price and consensus valuation forecast:
Basic company analysis:Lyra Therapeutics, Inc.
Core merchandise of lyratherapeutics.com

For Lyra Therapeutics, Inc. (LYRA), which develops biodegradable implants for the therapy of ENT diseases, the profit dynamics for the upcoming period reflect market confidence in the commercialization of its innovations. The daily recalculation of forward EPS expectations forms a historical trend for n+1 profit forecasts, mathematically capturing the probability of business scaling. The positive trajectory of this indicator confirms the asset's fundamental stability and the monetization potential of its developments.

Competitor analysis for Lyra Therapeutics, Inc.

Net earnings per share growth forecast for next year Haleon plc|Expected net earnings per share growth next year kenvue.com KVUE|Net earnings per share growth forecast for next year Verona Pharma (VRNA)|MENS (Jyong Biotech Limited) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ligand Pharma LGND|Earnings growth forecast for next year Amneal Corp AMRX|Perrigo Company PLC - Earnings growth forecast for next year|ALVO: Net earnings per share growth forecast for next year|liquidia.com (LQDA) - Net earnings per share growth forecast for next year|GLPG (Galapagos) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year ANIP|Projected earnings per share growth rate for next year MNKD (Afrezza)|Earnings growth forecast for next year AMPH|PCRX (Pacira BioSciences) - Expected earnings per share trend next year|Earnings growth forecast for next year SPRY (ARS Pharmaceuticals, Inc.)|Theravance Biopharma, Inc. - Net earnings per share growth forecast for next year|Aquestive Corp - Earnings growth forecast for next year|scpharmaceuticals.com (SCPH) - Expected earnings per share growth for next year|TECX: Earnings growth forecast for next year|Tonix Pharmaceuticals - Expected earnings per share trend next year|Expected earnings per share growth for next year SXTC|EPRX: Expected earnings per share trend next year|Expected earnings per share growth for next year BHST (BioHarvest Sciences Inc.)|Consensus forecast of earnings per share growth for next year Invizyne|Net earnings per share growth forecast for next year Oramed Pharmaceuticals ORMP|Expected earnings per share trend next year ENTX|HYFT - Net earnings per share growth forecast for next year|Expected earnings per share trend next year ABVC (ABVC BioPharma Inc.)|CPIX: Earnings growth forecast for next year|Quantum BioPharma Limited - Expected earnings per share trend next year|FGEN (FibroGen Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year Telomir Pharmaceuticals|Earnings growth forecast for next year RANI|SNYR (Synergy CHC Corp.) - Expected earnings per share trend next year|Earnings growth forecast for next year RLYB (Rallybio Corp)|LEXX: Projected earnings per share growth rate for next year|PULM - Net earnings per share growth forecast for next year|PTHL: Net earnings per share growth forecast for next year|APM (aptorumgroup.com) - Expected earnings per share growth for next year|IBO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year TNF Pharmaceuticals, Inc.|Expected earnings per share growth for next year cbdMD, Inc. (YCBD)|Net earnings per share growth forecast for next year PainReform Limited (PRFX)|Expected earnings per share growth for next year Altamira Therapeutics Ltd CYTO|Earnings growth forecast for next year LIPO (lipella.com)|Expected earnings per share trend next year OPTN|PIRS - Net earnings per share growth forecast for next year|Procaps Group Corp (PROC) - Expected earnings per share growth for next year|Petros (PTPI) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year QLI (Qilian International)|Expected earnings per share growth for next year SLRN|TFF Pharmaceuticals, Inc. - Net earnings per share change forecast for next year